| Q77805867 | A case of Aspergillus myocarditis associated with septic shock |
| Q34644855 | A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice |
| Q28540595 | A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist |
| Q36376760 | Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus |
| Q40268621 | Acquired immunity in experimental murine aspergillosis is mediated by macrophages. |
| Q37005496 | Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae |
| Q37404678 | Alarmins and antimicrobial immunity. |
| Q37878272 | Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis |
| Q34108392 | Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus |
| Q44504692 | An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group |
| Q34819510 | An acidic microenvironment increases NK cell killing of Cryptococcus neoformans and Cryptococcus gattii by enhancing perforin degranulation |
| Q67923521 | An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis |
| Q39734385 | An overview of macrophage-fungal interactions |
| Q36194619 | Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia. |
| Q41964909 | Antifungal Treatments Delineate a Correlation between Cathepsins and Cytokines in Murine Model of Invasive Aspergillosis |
| Q34109768 | Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum |
| Q69216244 | Aspergillosis |
| Q35038459 | Aspergillosis. Pathogenesis, clinical manifestations, and therapy |
| Q46817409 | Aspergillus bronchitis without significant immunocompromise. |
| Q40990613 | Aspergillus endophthalmitis. An unrecognized endemic disease in orthotopic liver transplantation |
| Q29617908 | Aspergillus fumigatus and aspergillosis |
| Q24811085 | Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display |
| Q39950603 | Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. |
| Q24681995 | Aspergillus fumigatus: principles of pathogenesis and host defense |
| Q33719294 | Aspergillus infections in transplant recipients |
| Q83786215 | Aspergillus osteomyelitis of the proximal humerus: a case report |
| Q35096777 | Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy |
| Q69368696 | Aspergillus, asthma, and amoebae |
| Q37077782 | Aspergillus-associated airway disease, inflammation, and the innate immune response |
| Q34426233 | Assessing anti-fungal activity of isolated alveolar macrophages by confocal microscopy |
| Q35527082 | Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. |
| Q44500220 | Bayesian development of a dose-response model for Aspergillus fumigatus and invasive aspergillosis |
| Q39830612 | Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. |
| Q30585324 | Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. |
| Q60129487 | Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis |
| Q39755181 | Catalases of Aspergillus fumigatus |
| Q70037170 | Cellular and humoral immune responses in experimental aspergillosis in mice |
| Q41528703 | Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China. |
| Q32065060 | Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. |
| Q34484754 | Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. |
| Q57765113 | Combined mucormycosis and aspergillosis of the oro-sinonasal region in a patient affected by Castleman disease |
| Q37005917 | Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions |
| Q35013359 | Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection |
| Q35091593 | Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations |
| Q44691591 | Constitutive and regulated expression of platelet basic protein in human monocytes |
| Q33604267 | Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease |
| Q37442775 | Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling |
| Q39518771 | Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus |
| Q58855414 | Cytokine- and T-helper-dependent immunity in murine aspergillosis |
| Q34577684 | Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation |
| Q36987939 | Detection of invasive aspergillosis in bone marrow transplant recipients using real-time PCR. |
| Q30360869 | Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic. |
| Q40734608 | Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis |
| Q38467076 | Differential gene expression in Aspergillus fumigatus induced by human platelets in vitro. |
| Q34238212 | Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro |
| Q71763720 | Disseminated aspergillosis in a dog: an immunohistochemical study |
| Q34297696 | Distinct innate immune phagocyte responses to Aspergillus fumigatus conidia and hyphae in zebrafish larvae. |
| Q37367171 | Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia |
| Q35220405 | Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia |
| Q45353811 | Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis |
| Q31161843 | Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys |
| Q34183291 | Endemic mycosis complicating human immunodeficiency virus infection |
| Q46202855 | Endogenous Aspergillus endophthalmitis in an immunocompetent individual |
| Q72302291 | Enhancement of human monocyte beta-glucan receptors by glucocorticoids |
| Q33618882 | Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon |
| Q37349900 | Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection |
| Q53800715 | Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin. |
| Q48172537 | Experimental central nervous system phaeohyphomycosis following intranasal inoculation of Xylohypha bantiana in cortisone-treated mice |
| Q40006952 | First reported case of Aspergillus granulosus infection in a cardiac transplant patient. |
| Q42872891 | Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration |
| Q41418345 | Fungal infections in patients with acquired immunodeficiency syndrome |
| Q30426339 | Fungal pulmonary complications |
| Q37622960 | Fungal spores: a critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting |
| Q35095656 | Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. |
| Q34562383 | Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes |
| Q36755328 | Gliotoxin Suppresses Macrophage Immune Function by Subverting Phosphatidylinositol 3,4,5-Trisphosphate Homeostasis |
| Q33697679 | Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression |
| Q39511215 | Granulocyte transfusions in neutropenic patients |
| Q34540865 | HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans |
| Q41843461 | Hematogenously acquired Aspergillus vertebral osteomyelitis in seemingly immunocompetent drug addicts. |
| Q35649657 | Host defence to pulmonary mycosis |
| Q40698555 | Host defenses against respiratory infection. |
| Q37990413 | Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection |
| Q37382381 | Host immune response against Scedosporium species |
| Q38223670 | Host-parasite interaction in fungal infections |
| Q39745381 | Host-parasite relationship in opportunistic mycoses |
| Q42001302 | Human dendritic cells following Aspergillus fumigatus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response |
| Q36376608 | Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury |
| Q32105390 | Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils |
| Q39035934 | Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation |
| Q40103200 | IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection. |
| Q43995112 | IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. |
| Q92571449 | Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus |
| Q37821488 | Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench |
| Q37186705 | Immunocompromised hosts: immunopharmacology of modern antifungals. |
| Q36870941 | Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors |
| Q38585600 | Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis |
| Q44468410 | Impaired phagocyte respiratory burst responses to opportunistic fungal pathogens in transplant recipients: in vitro effect of r-metHuG-CSF (Filgrastim). |
| Q35823358 | In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus |
| Q80215883 | In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes |
| Q34534366 | In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism |
| Q72387145 | Infectious complications in 100 consecutive heart transplant recipients |
| Q35649461 | Infectious disease, the innate immune response, and fibrosis |
| Q80282832 | Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species |
| Q37027946 | Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines. |
| Q33810700 | Innate Lung Defense during Invasive Aspergillosis: New Mechanisms |
| Q30434628 | Innate immunity to Aspergillus species |
| Q41045120 | Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi |
| Q53916641 | Interaction ofAspergillus FumigatusSpores and Pulmonary Alveolar Macrophages of Rabbits |
| Q34001207 | Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway. |
| Q36076185 | Intratracheal exposure of rats to Aspergillus fumigatus spores isolated from sawmills in Sweden |
| Q51685248 | Intubation practice on cadavers should stop. |
| Q56837355 | Invasive Aspergillosis as an Opportunistic Infection in Nonallografted Patients with Multiple Myeloma: A European Organization for Research and Treatment of Cancer |
| Q37556643 | Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature |
| Q41512386 | Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients |
| Q35616161 | Invasive aspergillosis in patients with hematologic malignancies. |
| Q40440616 | Invasive aspergillosis in systemic lupus erythematosus |
| Q40264475 | Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia |
| Q33874862 | Invasive fungal sinusitis in the acquired immunodeficiency syndrome. |
| Q49897827 | Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature |
| Q74592092 | Invasive pulmonary aspergillosis in an insulin-dependent diabetic |
| Q44138292 | Invasive pulmonary aspergillosis in immunocompromized children: diagnosis and classification |
| Q68796207 | Invasive pulmonary aspergillosis in the early postcardiac transplantation period |
| Q24290929 | Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae |
| Q43013642 | Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis. |
| Q37097947 | Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system |
| Q37100918 | Killing of Aspergillus spores depends on the anatomical source of the macrophage |
| Q39822116 | Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages |
| Q33901712 | Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus |
| Q61550094 | Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils |
| Q58803073 | Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing |
| Q34071588 | Management of fungal infections in neutropenic patients: more doubts than certainties? |
| Q38081230 | Minireview: host defence in invasive aspergillosis |
| Q30538643 | Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. |
| Q28114945 | Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production |
| Q23921897 | Murine models of airway fungal exposure and allergic sensitization |
| Q28391846 | N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp |
| Q33911333 | NOX2-dependent regulation of inflammation |
| Q40388517 | Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease |
| Q36246329 | Neutrophil Interactions Stimulate Evasive Hyphal Branching by Aspergillus fumigatus. |
| Q37035999 | Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia |
| Q48094065 | Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase. |
| Q36057930 | Neutrophils in host defense: new insights from zebrafish |
| Q34159058 | Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response |
| Q37020923 | Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages |
| Q37123905 | Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease |
| Q40932284 | Opportunistic infections in oncologic patients |
| Q36351838 | Oxygen-independent killing by alveolar macrophages |
| Q24650911 | Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis |
| Q74220464 | Perinephric abscess due to Aspergillus fumigatus |
| Q34154790 | Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages |
| Q40651047 | Persistent neutrophilic meningitis in a patient with the acquired immunodeficiency syndrome |
| Q77451382 | Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems |
| Q44671474 | Polyene and cytokine treatment of experimental aspergillosis |
| Q33614894 | Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon |
| Q69531570 | Proceedings of the British Thoracic Society. 1985 winter meeting. 11-12 December, London. Abstracts |
| Q68003654 | Progressive chronic pulmonary aspergillosis: a diagnostic and therapeutic challenge |
| Q34121622 | Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation |
| Q67710891 | Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice |
| Q34007073 | Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis |
| Q38038823 | Pulmonary Aspergillus intracavitary colonization (PAIC). |
| Q42572570 | Pulmonary aspergilloma in a patient with AIDS |
| Q44780505 | Pulmonary aspergillosis in acquired immune deficiency syndrome: autopsy study of an emerging pulmonary complication of human immunodeficiency virus infection |
| Q35889014 | Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications |
| Q77164094 | Pulmonary host defences against Aspergillus fumigatus |
| Q35433832 | Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. |
| Q33863956 | Putative virulence factors of Aspergillus fumigatus |
| Q41108756 | Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients |
| Q36040945 | Regulation of innate immunity by NADPH oxidase |
| Q42323203 | Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus |
| Q41127985 | Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells |
| Q37372812 | Restoration of NET formation by gene therapy in CGD controls aspergillosis |
| Q35847487 | Reversal of long-term sepsis-induced immunosuppression by dendritic cells. |
| Q24606804 | Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study |
| Q44841235 | Risk factors for systemic fungal infections in liver transplant recipients |
| Q33689767 | Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization. |
| Q37053120 | Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus influenzae from murine lungs. |
| Q72589223 | Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection |
| Q41056617 | Role of neutrophils in invasive aspergillosis |
| Q36313959 | Role of neutrophils in preventing and resolving acute fungal sinusitis |
| Q39391951 | Secretome of human bronchial epithelial cells in response to the fungal pathogen Aspergillus fumigatus analyzed by differential in-gel electrophoresis |
| Q30492852 | Selective detection of NADPH oxidase in polymorphonuclear cells by means of NAD(P)H-based fluorescence lifetime imaging |
| Q61510217 | Silencing of mitochondrial alternative oxidase gene of Aspergillus fumigatus enhances reactive oxygen species production and killing of the fungus by macrophages |
| Q40109690 | Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature. |
| Q34611574 | Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus |
| Q26774635 | Sphingolipids as Regulators of the Phagocytic Response to Fungal Infections |
| Q37209970 | Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs. |
| Q39866778 | Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients |
| Q30847680 | Sub-telomere directed gene expression during initiation of invasive aspergillosis |
| Q41126887 | Suppression of host defences by Aspergillus fumigatus |
| Q37911513 | T cell immunity and vaccines against invasive fungal diseases |
| Q34750420 | TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection |
| Q35567104 | Th1 and Th2 cytokines in mice with invasive aspergillosis. |
| Q92883935 | The Aspergillus fumigatus Mucin MsbA Regulates the Cell Wall Integrity Pathway and Controls Recognition of the Fungus by the Immune System |
| Q49312506 | The Aspergillus fumigatus Sialidase (Kdnase) Contributes to Cell Wall Integrity and Virulence in Amphotericin B-Treated Mice |
| Q24811208 | The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus |
| Q36442845 | The child with cancer and infection. II. Nonbacterial infections |
| Q36229261 | The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps |
| Q28387394 | The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection |
| Q34341968 | The pathobiology of Aspergillus fumigatus |
| Q33559140 | The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy |
| Q44582261 | The pathology of disseminated Aspergillus terreus infection in dogs |
| Q41254880 | The potential benefit of granulocyte transfusion therapy |
| Q35277785 | The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease |
| Q45114285 | The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary |
| Q33364468 | The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation |
| Q44243302 | The surgical management of fungal pulmonary infections in children with acute myelogenous leukemia |
| Q34563875 | Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon |
| Q89531338 | Three-Dimensional Light Sheet Fluorescence Microscopy of Lungs To Dissect Local Host Immune-Aspergillus fumigatus Interactions |
| Q47663189 | Tissue-Resident Macrophages in Fungal Infections |
| Q39419588 | Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases |
| Q33769906 | Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus |
| Q36981602 | Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis |
| Q40695013 | Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis |
| Q35967372 | Use of cytokines in infection |
| Q69127721 | Use of thin layer chromatography for detection and high performance liquid chromatography for quantitating gliotoxin from rice cultures of Aspergillus fumigatus fresenius |
| Q53949766 | Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. |
| Q35073715 | Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. |
| Q24683790 | Virulence factors of medically important fungi |
| Q40376384 | Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. |
| Q40722965 | What's new in fungal infection in leukemic patients |
| Q35038464 | Zygomycosis |
| Q42080318 | in-silico characterization of β-(1, 3)-endoglucanase (ENGL1) from Aspergillus fumigatus by homology modeling and docking studies |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.